Carboxypeptidase-b1

Show results for

Transcriptomics (19)
Unknown (17)
Proteomics (14)
Metabolomics (2)
Genomics (1)
Other (1)

Organisms

Homo sapiens (11)
Mus musculus (7)
synthetic construct (1)
Salmo salar (1)
Rattus norvegicus (1)
Sus scrofa (1)
Arabidopsis thaliana (1)
Schizosaccharomyces pombe (1)
Sinorhizobium meliloti BL225C (1)
Sus scrofa domesticus (1)
Saccharomyces cerevisiae (1)
Staphylococcus aureus (1)
Rattus norvegicus (1)
Escherichia coli (1)
Methylohalobius crimeensis 10Ki (1)
Homo sapiens (1)
Shigella flexneri (1)
Allexis (1)
Shigella (1)
Zea mays (1)
Medicago truncatula (1)
Listeria monocytogenes (1)
Entamoeba histolytica HM-1:IMSS-A (1)
Solanum tuberosum (1)
Arabidopsis thaliana (1)
Mus musculus (1)

Repository

biostudies-arrayexpress (19)
MassIVE (10)
jPOST (3)
MetaboLights (2)
EGA (1)
GPMDB (1)
pride (1)

Disease

Not Available (1)
Breast cancer (1)

Technology Type

Mass spectrometry assay (2)
Mass Spectrometry (1)
Shotgun proteomics (1)

Instrument Platform

Orbitrap Fusion (5)
Agilent Microarray Scanner G2505C (1)
Agilent Hybridisation Oven G2545A (1)
PC (1)
None (1)
2100 Bioanalyzer (Agilent, CA, USA), Qubit 2.0 (Invitrogen, Germany) (1)
NextSeq 1000 (1)
Illumina HiSeq 2500 (1)
Illumina HiSeq 4000 (1)
NextSeq 500 (1)
Instrument (1)
LC-ICPMS (1)
MALDI (1)
Compact (1)
Orbitrap Eclipse (1)
Q Exactive (1)
Liquid Chromatography MS - alternating - reverse-phase (1)
Liquid Chromatography MS - positive - reverse-phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)

Publication Date

2025 (5)
2014 (5)
2024 (5)
2023 (4)
2010 (4)
2015 (3)
2021 (2)
2026 (2)
2011 (1)
2009 (1)
2008 (1)
2007 (1)
2019 (1)

Metabolite Name

Galactinol (2)
Thymidine (2)
1-O-((3.beta.,5.Xi.,9.Xi.,18.Xi.,19.Xi.,20.Xi.)-3-((6-Deoxyhexopyranosyl)oxy)-27-hydroxy-27,28-dioxours-12-en-28-yl)-6-O-hexopyranosylhexopyranose (1)
MCULE-7407861812 (1)
NCGC00381308-01 (1)
Ncgc00169736-02!(3r,5r)-3,4,5-tris[[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-1-hydroxycyclohexane-1-carboxylic acid (1)
2-[2-[(E)-(Isonicotinoylhydrazono)methyl]phenoxy]acetic acid (1)
5-(4-Hydroxyphenyl)-1-[2-(4-hydroxyphenyl)ethyl]pentyl 2-O-D-apio-.beta.-D-furanosyl-.beta.-D-glucopyranoside (1)
Kaempferol 3-glucoside 7-rhamnoside (1)
CHEMBL2326941 (1)
Indigoticoside A (1)
12-Deoxyphorbol 13-laurate (1)
.beta.-Linoleoyl-.alpha.-glycerophosphorylcholine (1)
CHEBI:139416 (1)
17:0 Lyso PC (1)
Dilauroylphosphatidic acid (1)
SCHEMBL19999136 (1)
MEGxp0_001059 (1)
4-(4-(4-Hydroxy-3-methoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl)-2-methoxyphenyl hexopyranoside (1)
Maslic acid (1)
5-Hydroxy-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl 6-O-(3,4-dihydroxy-4-(hydroxymethyl)tetrahydrofuran-2-yl)hexopyranoside (1)
2-(4-Methylcyclohex-3-en-1-yl)propan-2-yl 6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranoside (1)
23-Hydroxytormentic acid (1)
6-O-.beta.-D-Glucopyranosyl-1-O-((3.beta.,5.xi.,9.xi.)-3,19,24-trihydroxy-24,28-dioxours-12-en-28-yl)-.beta.-D-glucopyranose (1)
3,19-Dihydroxyurs-12-ene-23,28-dioic acid (1)
1-O-(2,3,19,23-Tetrahydroxy-23,28-dioxours-12-en-28-yl)hexopyranose (1)
3,5-Di-O-caffeoyl-4-O-(3-hydroxy-3-methyl)glutaroylquinic acid (1)
2,7-Dihydroxy-8-(5-hydroxy-7-isopropyl-3-keto-4-methyloct-7-enyl)-4a,7-dimethyl-1,2,3,4,5,6,8,9,10,10a-decahydrophenanthrene-1-carboxylic acid (1)
Jasminoside R (1)
MMV689029 (1)

Study type

Transcription profiling by array (10)
Unknown experiment type (4)
RNA-seq of coding RNA (3)
ATAC-seq (1)
MicroRNA profiling by array (1)

Release Date

2014 (7)
2010 (4)
2025 (3)
2015 (3)
2011 (2)
2022 (2)
2021 (2)
2018 (2)
2017 (2)
2016 (2)
2023 (1)
2009 (1)
2008 (1)
2007 (1)
2026 (1)
2019 (1)
2013 (1)

Lab affiliation

Masaryk Memorial Cancer Institute, Regional Centre for Applied Molecular Oncology and Masaryk University, Faculty of Science, Brno, Czech Republic (1)

Previous page
1 / 6
You're on page 1
page 2
page 3
page 4
page 5
page 6
Next page

Sort by:

Relevance

Page size

Combined proteomics and transcriptomics identifies carboxypeptidase B1 and NF-κB associated proteins as putative biomarkers of metastasis in low grade breast cancer

Current prognostic factors are insufficient for precise risk-discrimination in breast cancer patients with low grade breast tumors, which, in disagreement with theoretical prognosis, occasionally form early lymph node metastasis. To identify markers for this group of patients, we employed iTRAQ-2DLC...

ORGANISM(S): Homo sapiens (Human)

2015-04-23 | PXD000029 | Pride